Clinical trial · Observational
Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma
NCT05451134CI-TRIAL-00059597unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators will retrospectively analyze the clinical data of consecutive patients with pheochromocytomas and paragangliomas admitted between January 2018 and June 2020. The clinical characteristics of patients with and without dysglycemia will be compared, and whether surgery could improve the patients'dysglycemia will be also investigated.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Paraganglioma | Paraganglioma | ONTOLOGY_EXACT | 0.98 |
| Pheochromocytoma | Adrenal Gland Pheochromocytoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Catecholamines | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- patients with dysglycemia
- description
- Patients with dysglycemia in the included subjects with pheochromocytoma and paraganglioma
- interventionNames
- Other: Catecholamines
- label
- patients without dysglycemia
- description
- Patients without dysglycemia in the included subjects with pheochromocytoma and paraganglioma
- interventionNames
- Other: Catecholamines
Primary outcomes (1)
- measure
- Change from baseline OGTT（oral glucose tolerance test）results to 6-12 months after surgery
- timeFrame
- Baseline, 6-12 months after surgery
- description
- OGTT results （including fasting blood glucose in the text, blood glucose results at 2 hours after oral administration of 75g glucose）at baseline and 6-12 months after surgery will be recorded to assess the effect of surgery on dysglycemia
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * age ≥18 years old * patients with surgical pathological diagnosis of pheochromocytomas and paragangliomas(PPGLs) Exclusion Criteria: * recurrent PPGLs * patients who required steroids after adrenalectomy * patients with inadequate clinical records were excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.